Jan Roodt

1.2k total citations
30 papers, 980 citations indexed

About

Jan Roodt is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jan Roodt has authored 30 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 8 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jan Roodt's work include Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (8 papers) and Complement system in diseases (6 papers). Jan Roodt is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (8 papers) and Complement system in diseases (6 papers). Jan Roodt collaborates with scholars based in South Africa, Belgium and United States. Jan Roodt's co-authors include Seb Lamprecht, Hans Deckmyn, P N Badenhorst, Muriel Meiring, Walter J. Janse van Rensburg, A. du P. Heyns, Stefaan Rossenu, Sofie Priem, Hans Ulrichts and Josefin-Beate Holz and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Pharmaceutical Sciences.

In The Last Decade

Jan Roodt

30 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Roodt South Africa 16 586 326 169 138 132 30 980
Amy M. Bertino United States 7 510 0.9× 220 0.7× 48 0.3× 82 0.6× 47 0.4× 11 903
Katalin Váradi Austria 21 1.5k 2.6× 376 1.2× 184 1.1× 22 0.2× 101 0.8× 55 1.8k
Ole Nordfang Denmark 25 1.1k 1.9× 73 0.2× 200 1.2× 26 0.2× 14 0.1× 50 1.4k
Visalam Chandrasekaran United States 11 1.1k 1.9× 1.1k 3.3× 37 0.2× 67 0.5× 458 3.5× 13 1.7k
C N Chesterman Australia 15 336 0.6× 133 0.4× 130 0.8× 9 0.1× 29 0.2× 32 775
Hiroshi Tsutani Japan 16 439 0.7× 176 0.5× 23 0.1× 28 0.2× 123 0.9× 82 979
Peter A.W. te Boekhorst Netherlands 21 582 1.0× 113 0.3× 15 0.1× 208 1.5× 18 0.1× 50 1.1k
Yvette C. Tanhehco United States 13 388 0.7× 158 0.5× 25 0.1× 20 0.1× 24 0.2× 49 1.1k
Debjit Biswas United States 8 220 0.4× 414 1.3× 46 0.3× 6 0.0× 189 1.4× 12 777
Patricia Molina Spain 15 157 0.3× 71 0.2× 212 1.3× 65 0.5× 32 0.2× 31 776

Countries citing papers authored by Jan Roodt

Since Specialization
Citations

This map shows the geographic impact of Jan Roodt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Roodt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Roodt more than expected).

Fields of papers citing papers by Jan Roodt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Roodt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Roodt. The network helps show where Jan Roodt may publish in the future.

Co-authorship network of co-authors of Jan Roodt

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Roodt. A scholar is included among the top collaborators of Jan Roodt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Roodt. Jan Roodt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schöchl, Herbert, Martijn van Griensven, Stefan Heitmeier, et al.. (2017). Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis. Critical Care. 21(1). 51–51. 12 indexed citations
2.
Tersteeg, Claudia, Jan Roodt, Walter J. Janse van Rensburg, et al.. (2016). N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura. Blood. 129(8). 1030–1038. 47 indexed citations
3.
Rensburg, Walter J. Janse van, P N Badenhorst, & Jan Roodt. (2014). The Cape Chacma baboon is not suitable for evaluating human targeted anti-GPVI agents. Platelets. 26(6). 552–557. 4 indexed citations
4.
Feys, Hendrik B., Jan Roodt, Nele Vandeputte, et al.. (2012). Inhibition of von Willebrand factor–platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons. Blood. 120(17). 3611–3614. 27 indexed citations
5.
Callewaert, Filip, Jan Roodt, Hans Ulrichts, et al.. (2012). Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura. Blood. 120(17). 3603–3610. 106 indexed citations
6.
Rensburg, Walter J. Janse van, Jan Roodt, Seb Lamprecht, Muriel Meiring, & P N Badenhorst. (2012). Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates. Clinical and Experimental Medicine. 12(4). 257–263. 4 indexed citations
7.
Jacquemin, Marc, J M Stassen, Peter Verhamme, et al.. (2008). A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons. Journal of Thrombosis and Haemostasis. 7(3). 429–437. 17 indexed citations
8.
Fontayne, Alexandre, et al.. (2008). The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons. Thrombosis and Haemostasis. 100(10). 670–677. 54 indexed citations
9.
Badenhorst, P N, Seb Lamprecht, Jan Roodt, et al.. (2007). Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor - collagen interaction in baboons. Thrombosis and Haemostasis. 98(12). 1343–1349. 13 indexed citations
10.
Goodrich, Raymond P., et al.. (2006). Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sanguinis. 90(4). 279–285. 106 indexed citations
11.
Fontayne, Alexandre, Karen Vanhoorelbeke, Inge Pareyn, et al.. (2006). Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4.. PubMed. 96(5). 671–84. 27 indexed citations
12.
Fontayne, Alexandre, Karen Vanhoorelbeke, Inge Pareyn, et al.. (2006). Rational humanization of the powerful antithrombotic anti-GPIbα antibody: 6B4. Thrombosis and Haemostasis. 96(11). 671–684. 23 indexed citations
13.
Kotzé, H F, et al.. (2000). Determination of the Dosage of Recombinant Hirudin to Inhibit Arterial Thrombosis in Baboons. Journal of Pharmaceutical Sciences. 89(5). 579–585. 1 indexed citations
14.
Roodt, Jan, et al.. (2000). The Effect of Monoclonal Anti-human-platelet Antibodies on Platelet Kinetics in a Baboon Model: IgG Subclass Dependency. Thrombosis and Haemostasis. 83(1). 148–156. 11 indexed citations
15.
Kotzé, H F, et al.. (1997). Transient Interruption of Arterial Thrombosis by Inhibition of Factor Xa Results in Long-term Antithrombotic Effects in Baboons. Thrombosis and Haemostasis. 77(6). 1137–1142. 13 indexed citations
16.
17.
Kotzé, H F, et al.. (1993). Influence of Platelet Membrane Sialic Acid and Platelet-Associated IgG on Ageing and Sequestration of Blood Platelets in Baboons. Thrombosis and Haemostasis. 70(4). 676–680. 31 indexed citations
18.
Holme, S., Andrew Heaton, & Jan Roodt. (1993). Concurrent label method with 111In and 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates. British Journal of Haematology. 84(4). 717–723. 51 indexed citations
19.
Kotzé, H F, A. du P. Heyns, M. G. Lötter, et al.. (1991). Comparison of oxine and tropolone methods for labeling human platelets with indium-111.. PubMed. 32(1). 62–6. 24 indexed citations
20.
Badenhorst, P N, A. du P. Heyns, H F Kotzé, Jan Roodt, & M. G. Lötter. (1990). In-111-labeled platelet kinetic studies identify those patients with chronic ITP who will respond to intravenous gammaglobulin.. PubMed. 355. 97–104. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy M. Bertino Breakdown of academic impact, for papers by Katalin Váradi Breakdown of academic impact, for papers by Ole Nordfang Breakdown of academic impact, for papers by Visalam Chandrasekaran Breakdown of academic impact, for papers by C N Chesterman Breakdown of academic impact, for papers by Hiroshi Tsutani Breakdown of academic impact, for papers by Peter A.W. te Boekhorst Breakdown of academic impact, for papers by Yvette C. Tanhehco Breakdown of academic impact, for papers by Debjit Biswas Breakdown of academic impact, for papers by Patricia Molina
Rankless by CCL
2026